Magnus Simren

Plain English
This study looked at patients experiencing bloating and belly distention to better understand their symptoms and the factors affecting their quality of life. Researchers analyzed survey data from 3,471 participants and identified six distinct groups based on their symptoms, dietary habits, and psychological factors. For example, two of the groups had severe bowel issues and reported the most significant health impairments, while others experienced milder symptoms and better overall quality of life. Who this helps: This research benefits patients dealing with bloating and gastrointestinal issues by providing insights that can lead to more tailored treatments.

Plain English
This study looked at how the COVID-19 pandemic affected the prevalence of gut-brain disorders, which include issues like functional dyspepsia and irritable bowel syndrome. After the pandemic, the number of people diagnosed with these disorders increased from 38.3% to 42.6%. This rise was linked to factors such as younger age, female sex, anxiety, and the experience of long COVID, which led to a lower quality of life for those affected. Who this helps: This research benefits patients suffering from gut-brain disorders and long COVID, as well as their healthcare providers.

Plain English
This study looked at how feelings of shame affect people with bowel disorders linked to the gut and brain. Researchers found that those with these conditions reported much higher levels of shame—56% more—compared to those without bowel symptoms. This shame can worsen feelings of anxiety and depression, and lower overall quality of life for patients. Who this helps: This research benefits patients with bowel disorders and their healthcare providers.

Plain English
This study looked at how additional health problems, like anxiety and chronic fatigue, affect people with Irritable Bowel Syndrome (IBS). It found that 607 IBS patients with these extra conditions experienced much worse symptoms and overall health issues compared to IBS patients without them. Specifically, as the number of additional health problems increased, their IBS symptoms worsened significantly. This research is important because it highlights the need for better treatment approaches for IBS patients dealing with other health issues. Who this helps: Patients with IBS and their healthcare providers.

Plain English
This study looked at how often people with Irritable Bowel Syndrome (IBS) and Functional Dyspepsia (FD) experience bloating and visible abdominal swelling, both of which are related to gas. Researchers found that nearly 65% of people with IBS and 51% with FD reported bloating, with the number rising to 88.5% for those with both conditions, compared to just 14% in healthy individuals. This is important because it highlights that bloating and swelling are common and significant symptoms in IBS and FD, suggesting these should be considered when diagnosing these conditions. Who this helps: This benefits patients with IBS and FD by improving diagnosis and understanding of their symptoms.

Plain English
This research paper looks at bowel disorders, which are common conditions that affect people of all ages and backgrounds. The study introduces the new Rome V classification system that sorts these disorders into six categories, including irritable bowel syndrome and chronic constipation, to improve how they are diagnosed and treated. This is important because better classification can lead to better care and quality of life for those suffering from these issues. Who this helps: Patients with bowel disorders and their doctors benefit from this improved understanding and categorization.

Plain English
Researchers developed new diagnostic questionnaires called Rome V for adults and children to help identify digestive problems known as disorders of gut-brain interaction (DGBI). The updated questionnaires include better response options and additional questions that can help diagnose more conditions than the previous version, identifying 3 new DGBI for adults and 14 for children. Testing showed that these new questionnaires work as effectively as the older version, making them useful for both research and clinical practice. Who this helps: This benefits patients experiencing digestive issues and their doctors.

Plain English
Researchers created a shorter version of a questionnaire called the Central Sensitization Inventory (CSI) to better assess symptoms related to central sensitization, which is often seen in chronic pain conditions. They tested the new 7-item version, called CSI-7, using data from 7,862 people across 23 countries and found it effectively identifies different levels of symptoms, particularly distinguishing fibromyalgia from healthy individuals with 92% sensitivity and 93% specificity. This shorter questionnaire is easier to use in both research and clinical practices, making it more efficient for doctors to assess patients with chronic pain. Who this helps: This helps patients suffering from chronic pain by providing healthcare professionals a more efficient way to assess their symptoms.

Plain English
This study looked at how different symptoms of gut-brain interaction disorders (DGBI) are categorized in patients from Eastern and Western regions. Researchers analyzed data from 1,074 patients and found 10 unique groups of symptoms related to DGBI, some of which did not fit neatly into the existing classification system. This matters because it reveals that symptoms can span multiple areas of the gastrointestinal tract, suggesting that current diagnostic criteria may need to be updated to reflect this complexity. Who this helps: Patients experiencing DGBI symptoms who may not fit existing diagnostic categories.

Plain English
This study looked at how patients with irritable bowel syndrome (IBS) report their symptoms using two different methods: real-time assessments throughout the day and end-of-day diaries. Researchers found that the real-time method gave more accurate and consistent results than the end-of-day reports, with daily symptom scores being significantly lower by an average of about 1.2 points. This is important because it shows that using real-time tracking can help doctors better understand patients' conditions and tailor treatments more effectively. Who this helps: This benefits patients with IBS, as well as their doctors.

Plain English
This study looked at how common abdominal pain is in patients with ulcerative colitis (UC) and what factors contribute to it. They found that 63% of patients with active UC reported abdominal pain, compared to only 54% of those in a quiet (quiescent) phase. Additionally, 71% of patients had pain at diagnosis, which decreased to 46% when they were in remission. Factors like active disease, being female, and having anxiety were linked to higher levels of pain. This is important because it shows that abdominal pain is a significant issue for many UC patients, affecting their quality of life. Who this helps: Patients with ulcerative colitis, especially those experiencing abdominal pain.

Plain English
This study looked at specific markers in fecal samples to understand what happens in the intestines of people with irritable bowel syndrome (IBS). Researchers found that certain proteins related to epithelial cells were higher in IBS patients compared to healthy individuals, with significant changes in three markers (HNL, EDN, HPLBII-P) especially after treatment with mesalazine. This is important because it suggests that the function of intestinal cells, rather than inflammation, plays a key role in IBS, and these markers could help monitor the condition. Who this helps: This helps patients with IBS and their doctors in managing the condition more effectively.

Plain English
This study examined the effectiveness and safety of the drug PD-217,014 in treating irritable bowel syndrome (IBS), focusing on reducing abdominal pain. Researchers involved 330 participants and found that neither of the tested doses (150 mg or 300 mg) provided significant relief from abdominal pain compared to a placebo. This is important because it indicates that PD-217,014 is not an effective treatment for IBS despite being well-tolerated. Who this helps: This helps patients suffering from IBS by clarifying which treatments may not work for them.

Plain English
This study focused on improving the way therapies that combine brain and gut treatments are developed and tested for disorders that affect both organs, known as disorders of gut-brain interaction. The research team created a guideline for clinical trials that outlines specific steps for developing these therapies, emphasizing that they should follow a structured process similar to drug development. Their recommendations aim to enhance the quality and effectiveness of these treatments, which is crucial for advancing patient care. Who this helps: This helps patients with gut-brain disorders and the doctors treating them.

Plain English
This study looked at patients with gut-brain interaction disorders and found that many also have other health issues, like fibromyalgia and headaches, which can affect treatment and outcomes. Specifically, these overlapping conditions are common and complicate diagnosis and management strategies. Understanding this overlap is important because it can help doctors provide better care. Who this helps: This benefits patients dealing with gut-brain disorders and their associated symptoms.

Plain English
This study looked at how gluten and wheat affect people with irritable bowel syndrome (IBS) and those who are sensitive to gluten or wheat but do not have celiac disease (NCGWS). Researchers found that certain antibodies in IBS patients might help identify who could benefit from a gluten-free diet, while low levels of a specific marker in stool can help tell apart IBS from NCGWS. Ultimately, they concluded that while gluten's role might have been overstated, components of wheat and the connection between the gut and brain are still important in understanding these conditions. Who this helps: This information can benefit patients dealing with IBS and NCGWS, as well as their doctors in treatment decisions.

Plain English
This study looked at how common gut-brain interaction disorders (DGBI) are in people with obesity and how treatment for obesity affects these disorders. Researchers found that the percentage of patients showing symptoms of DGBI decreased from 61% before treatment to 53% after treatment, indicating a positive shift in gut health. This is important because improving gut health can enhance overall well-being and quality of life for those struggling with obesity. Who this helps: Patients with obesity.

Plain English
This study looked at how consistent doctors are when using a special imaging technique called confocal laser endomicroscopy to see if certain foods cause damage in the intestines of patients with irritable bowel syndrome (IBS). Researchers checked 119 recordings and found that individual doctors generally agreed on their assessments 80%-100% of the time, while agreement between different doctors was about 85%. This matters because it shows that this imaging technique is reliable and can help identify food-related intestinal issues effectively. Who this helps: Patients with irritable bowel syndrome and their doctors.

Plain English
This research looked at how common gut-brain interaction disorders (DGBI) are among people with obesity in Europe compared to those who are of normal weight or overweight. They found that 44.2% of obese individuals reported symptoms of DGBI, compared to 39.6% of normal weight or overweight individuals. This is important because it highlights the need for healthcare professionals to consider these gut-related symptoms in their treatment plans for obese patients. Who this helps: This benefits patients with obesity and their doctors.

Plain English
This study looked at how the speed at which food moves through the digestive system relates to the symptoms experienced by people with irritable bowel syndrome (IBS). It was found that issues with how quickly food moves through different parts of the gut are linked to symptoms like bowel irregularity, though the exact relationship isn’t fully understood yet. Understanding these connections is important because it can help improve treatment for IBS patients. Who this helps: Patients with irritable bowel syndrome.

Plain English
This paper reviews how gastrointestinal (GI) problems relate to hypermobile Ehlers-Danlos syndrome (hEDS) and associated conditions like postural orthostatic tachycardia syndrome (POTS) and mast cell activation syndrome (MCAS). It highlights that testing for POTS or MCAS should be targeted and not done routinely for every patient with hEDS/HSD, and suggests that certain symptoms can guide doctors in diagnosis and treatment. This information matters because it helps healthcare providers better manage GI symptoms and overall care for affected patients, improving their quality of life. Who this helps: This helps patients with hypermobile Ehlers-Danlos syndrome and their doctors.

Plain English
This study looked at how common and impactful gas-related gut symptoms are in people from the United States, the United Kingdom, and Mexico. Researchers surveyed 5,978 adults and found that 89% experienced at least one symptom in the last day, with flatulence being the most reported at 81%. Those with more severe gas symptoms reported poorer quality of life, higher stress, and more visits to the doctor. Who this helps: This information benefits patients dealing with gastrointestinal issues and their healthcare providers.

Plain English
This study investigated how common functional dyspepsia (FD) is worldwide and its effects on people's lives. It found that about 7.2% of people surveyed experience FD, with women being more affected and prevalence decreasing as people age. Those with FD often face higher rates of anxiety and depression, have a lower quality of life, and seek more medical help. Who this helps: This information is valuable for patients with gastrointestinal issues, doctors, and mental health professionals.

Plain English
This study looked at the long-term effects of a type of therapy called gut-directed hypnotherapy that nurses provide for people with irritable bowel syndrome (IBS). Out of 289 patients who completed a 12-week program, around 64% reported significant symptom relief right after treatment, and this relief continued after 2 years for about 62% of them. This finding is important because it shows that nurse-administered hypnotherapy can lead to lasting improvements in IBS symptoms. Who this helps: This helps patients with irritable bowel syndrome, particularly those seeking effective long-term treatments.

Plain English
This study examined how common it is for people around the world to have had their gallbladders removed (a surgery called cholecystectomy) and whether this surgery affects gut health. They found that about 5% of people reported having this surgery, with rates varying by region—from 1.9% in Asia to 9.9% in North America. Those who had their gallbladders removed were more likely to experience gastrointestinal issues, with 56.2% reporting symptoms compared to 42.3% of those without the surgery, especially related to stomach, bowel, and anal disorders. Who this helps: This information benefits patients who have had gallbladder surgery and their doctors.

Plain English
This study looked at how many people avoid or restrict their eating habits, comparing those with bowel symptoms to those without. They found that 22.8% of people with bowel symptoms showed these eating habits, compared to 18.2% of those without, indicating that those suffering from bowel issues might struggle more with their eating. The findings highlight the importance of addressing eating behaviors, especially since individuals with bowel symptoms often report more severe psychological and physical issues. Who this helps: This research helps patients with bowel symptoms and their healthcare providers.

Plain English
This study looked at how common Functional Bowel Disorders (FBD) are around the world and how they affect people’s lives. Researchers found that about 33.2% of people studied had FBD, with functional constipation being the most frequent type at 11.7%. People with these disorders reported more emotional and physical issues, a lower quality of life, and visited doctors more often, which is especially true for those with Irritable Bowel Syndrome (IBS). Who this helps: This information benefits patients suffering from bowel disorders and their healthcare providers.

Plain English
The study looked at how common occasional constipation (OC) is around the world and how it affects people's lives. It found that 7.4% of people surveyed experienced OC, with numbers varying by region—4.3% in the Middle East to 15.8% in Eastern Europe. People with OC not only had lower quality of life scores (14.5 physical and 13.5 mental) compared to those without constipation but also reported higher levels of anxiety and depression. Who this helps: This helps patients dealing with occasional constipation and their healthcare providers.

Plain English
This study looked at certain types of bacteria in the gut that can produce serotonin, a chemical that helps control bowel movements. Researchers found that two specific bacteria, Limosilactobacillus mucosae and Ligilactobacillus ruminis, not only made serotonin but also increased the number of nerve cells in the gut when tested in mice. Additionally, they noticed that people with irritable bowel syndrome had lower levels of the bacteria that produce serotonin, indicating a potential link between gut health and serotonin levels. Who this helps: This benefits patients with gut disorders, especially those with irritable bowel syndrome.

Plain English
This study looked at how people with irritable bowel syndrome (IBS) react to a meal using a non-invasive test called the lactulose nutrient challenge test (LNCT). The researchers found that 76% of IBS patients were hypersensitive during the test, meaning they experienced more severe symptoms like abdominal pain and bloating compared to healthy individuals. This matters because it helps identify specific factors that contribute to meal-related symptoms in IBS, which can lead to better management strategies for patients. Who this helps: This helps patients with IBS by providing insights that can guide their treatment.

Plain English
This study examined how common fecal incontinence (FI) is around the world and what factors are linked to it. Researchers found that 13.8% of people experienced some accidental stool leakage in the last three months, with higher rates in North America (19.7%) compared to Eastern Europe (10.9%). The study also discovered that FI is more likely to occur in older people, men, and those who are obese, and it significantly impacts quality of life. Who this helps: This benefits patients dealing with fecal incontinence, as well as healthcare providers seeking to improve care.

Plain English
This study looked at how often people with functional dyspepsia (a digestive issue) experience nausea related to meals. Among nearly 1,100 patients surveyed, those with a specific type of dyspepsia called the PDS-EPS overlap reported nausea more often than others, and 85% of those with meal-related nausea felt it within an hour after eating. Understanding the relationship between food and nausea in these patients is important for developing targeted treatments. Who this helps: This helps patients struggling with functional dyspepsia and their doctors in managing nausea better.

Plain English
This study looked at how COVID-19 affects people's gut health, particularly those who develop new gut-brain issues after recovering from the virus. Out of 599 patients, 27 (or about 4.5%) developed new gastrointestinal problems, experiencing increased abdominal pain and other symptoms, while others with pre-existing gut issues showed improvements in most symptoms. The findings highlight that those with post-COVID gut issues face ongoing digestive distress and emotional struggles, emphasizing the need for specific treatments for these patients. Who this helps: Patients who developed gastrointestinal issues after COVID-19 and their healthcare providers.

Plain English
This study examined how COVID-19 is linked to the development of irritable bowel syndrome (IBS) by looking at 623 patients over a year. Researchers found that symptoms like difficulty breathing, acid reflux, and hunger pains significantly increased the risk of developing IBS after COVID-19, with some symptoms affecting the risk as much as 3.5 times. Understanding these connections is important because it highlights specific symptoms that can signal a higher risk for IBS, allowing for better treatment and prevention strategies. Who this helps: This helps patients recovering from COVID-19 who may experience digestive issues.

Plain English
This study compared the effects of two specific diets—one low in certain fermentable sugars and one low in carbohydrates—against standard medical treatment for people with irritable bowel syndrome (IBS). After four weeks, 76% of those on the low FODMAP diet and 71% on the low-carb diet showed significant improvement in their IBS symptoms, compared to 58% of those receiving medical treatment. This research suggests that dietary changes may be a better first option for managing IBS symptoms than medication alone. Who this helps: This helps patients with irritable bowel syndrome looking for effective treatment options.

Plain English
This study looked at how different foods and drinks are linked to symptoms in people with irritable bowel syndrome (IBS), using data from nearly 10,000 food diaries collected through a smartphone app. The researchers found that caffeinated coffee often led to diarrhea within 1-2 hours, while alcohol and artificial sweeteners triggered multiple symptoms like bloating and gas between 4 to 72 hours after consumption. Understanding these links is important because it can help doctors and patients make better dietary choices to manage IBS symptoms. Who this helps: This helps patients with irritable bowel syndrome seeking to manage their symptoms through diet.

Plain English
This research studied different brain-gut behavioral treatments (BGBTs) for reducing abdominal pain in people with irritable bowel syndrome (IBS). The analysis included 42 studies with over 5,200 participants, finding that self-guided cognitive behavioral therapy (CBT) helped 29% of patients, face-to-face multicomponent behavioral therapy helped 28%, and face-to-face gut-directed hypnotherapy helped 23% in improving their pain. These results matter because they highlight effective non-drug options for a common yet distressing IBS symptom. Who this helps: This benefits patients suffering from abdominal pain due to irritable bowel syndrome.

Plain English
This research paper looks at the idea that small intestinal bacterial overgrowth (SIBO) might be linked to symptoms in people with irritable bowel syndrome (IBS) and similar disorders. The researchers found that, despite over 20 years of study, the connection between SIBO and these symptoms is not proven and that the reliance on breath tests for diagnosis has led to wrong treatments, including unnecessary antibiotic use. This matters because it highlights the need for better methods to understand and treat gut issues without relying on unvalidated tests. Who this helps: This helps patients with IBS and related disorders.

Plain English
This study looked at how common gut-brain interaction disorders (DGBI), like irritable bowel syndrome and constipation, are among older adults compared to younger individuals. It found that 41.9% of people under 65 have these disorders, while only 31.9% of those 65 and older do. Despite older adults having lower rates, there are still many who are affected, indicating a need for doctors to pay attention to DGBI in older patients and consider tailored treatments. Who this helps: This benefits older patients and their healthcare providers.

Plain English
This study looked at how often people with certain digestive diseases, like inflammatory bowel disease (IBD) or gastrointestinal cancer, also experience symptoms related to gut-brain interaction (DGBI). In a survey of over 54,000 adults from 26 countries, they found that having an organic GI disease significantly increases the chances of having DGBI symptoms, with IBD patients facing the highest odds of 3.22 times more likely to report these symptoms compared to those without these conditions. Understanding the connection between these symptoms and digestive diseases is important for better treatment and care management. Who this helps: This research benefits patients with digestive diseases and their doctors by highlighting the importance of considering gut-brain interaction symptoms in treatment plans.

Plain English
This study looked at how patients with irritable bowel syndrome (IBS) felt about making dietary changes in a structured program designed to help manage their symptoms. Researchers interviewed 19 patients on two different restrictive diets for four weeks. They found that while patients appreciated the support in making dietary changes, many found it difficult because it affected other parts of their lives. However, this process also led them to think more about their eating habits and make personal adjustments that suited their preferences. Who this helps: This benefits patients with IBS who are trying to manage their symptoms through diet.

Plain English
This study looked at how fecal samples from patients with colon cancer and ulcerative colitis affect the cells lining the colon. Researchers found that these fecal samples changed the activity of many genes in the colon cells: for instance, 29 genes were less active in ulcerative colitis patients compared to colon cancer patients, while 33 genes were more active. Understanding these changes could help us learn more about how these diseases work. Who this helps: This research benefits patients with colon cancer and ulcerative colitis.

Plain English
Researchers studied a bacterium that can cause intestinal problems like diarrhea and abdominal pain by sticking to the cells lining the colon. They found that a protein called BPP43_05035 helps this bacterium attach to these cells, which damages the protective barrier in the intestines, making it easier for harmful substances to pass through. Specifically, patients with higher levels of this protein showed reduced function of important protective genes in their intestines. Who this helps: This helps patients suffering from intestinal infections and their doctors by providing insights into the mechanisms behind their symptoms.

Plain English
This study looked at the diets of 646 patients with irritable bowel syndrome (IBS) and compared them to a matched group of 646 people without IBS. It found that IBS patients consumed fewer carbohydrates and had a lower quality diet, with only about 29% having a good diet quality compared to the general population. Understanding these dietary differences can help improve dietary management for IBS patients, potentially reducing their symptoms. Who this helps: Patients with irritable bowel syndrome.